TEVA B1 (Letrozole 2.5 mg)
Pill imprint TEVA B1 has been identified as Letrozole 2.5 mg.
Letrozole is used in the treatment of female infertility; breast cancer, metastatic; breast cancer, adjuvant; breast cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 2.5 mg
- Prescription only
FD&C Blue No. 2
FD&C Yellow No. 5
ferric oxide yellow
sodium starch glycolate type A potato
More about letrozole
- Other brands: Femara
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.